MX2022003091A - Retroelemento bacteriano modificado con produccion de adn mejorada. - Google Patents

Retroelemento bacteriano modificado con produccion de adn mejorada.

Info

Publication number
MX2022003091A
MX2022003091A MX2022003091A MX2022003091A MX2022003091A MX 2022003091 A MX2022003091 A MX 2022003091A MX 2022003091 A MX2022003091 A MX 2022003091A MX 2022003091 A MX2022003091 A MX 2022003091A MX 2022003091 A MX2022003091 A MX 2022003091A
Authority
MX
Mexico
Prior art keywords
retroelement
retrons
engineered
modified bacterial
dna production
Prior art date
Application number
MX2022003091A
Other languages
English (en)
Spanish (es)
Inventor
Seth Shipman
Original Assignee
The J David Gladstone Inst A Testamentary Trust Established Under The Will Of J David Gladstone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The J David Gladstone Inst A Testamentary Trust Established Under The Will Of J David Gladstone filed Critical The J David Gladstone Inst A Testamentary Trust Established Under The Will Of J David Gladstone
Publication of MX2022003091A publication Critical patent/MX2022003091A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07049RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/80Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/179Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
MX2022003091A 2019-09-12 2020-09-11 Retroelemento bacteriano modificado con produccion de adn mejorada. MX2022003091A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962899625P 2019-09-12 2019-09-12
PCT/US2020/050323 WO2021050822A1 (en) 2019-09-12 2020-09-11 Modified bacterial retroelement with enhanced dna production

Publications (1)

Publication Number Publication Date
MX2022003091A true MX2022003091A (es) 2022-06-08

Family

ID=74865645

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022003091A MX2022003091A (es) 2019-09-12 2020-09-11 Retroelemento bacteriano modificado con produccion de adn mejorada.

Country Status (11)

Country Link
US (3) US20220307007A1 (enExample)
EP (1) EP4028512A4 (enExample)
JP (2) JP2022548062A (enExample)
KR (1) KR20220081988A (enExample)
CN (2) CN119859624A (enExample)
AU (1) AU2020346880B2 (enExample)
BR (1) BR112022004453A2 (enExample)
CA (1) CA3154384A1 (enExample)
IL (1) IL291128A (enExample)
MX (1) MX2022003091A (enExample)
WO (1) WO2021050822A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4384616A4 (en) * 2021-08-11 2025-08-27 Univ Leland Stanford Junior HIGH-THROUGHPUT PRECISION GENOME EDITING IN HUMAN CELLS
EP4426832A1 (en) * 2021-11-03 2024-09-11 The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone Precise genome editing using retrons
US11866728B2 (en) 2022-01-21 2024-01-09 Renagade Therapeutics Management Inc. Engineered retrons and methods of use
US20250223586A1 (en) * 2022-03-25 2025-07-10 The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Methods of assessing engineered retron activity, and uses thereof
WO2023183627A1 (en) * 2022-03-25 2023-09-28 The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone Production of reverse transcribed dna (rt-dna) using a retron reverse transcriptase from exogenous rna
US20250215422A1 (en) * 2022-03-25 2025-07-03 The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glads RT-DNA Fidelity and Retron Genome Editing
US20250230429A1 (en) * 2022-04-07 2025-07-17 The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glads Continuous Multiplexed Phage Genome Engineering Using a Retron Editing Template
WO2024044673A1 (en) * 2022-08-24 2024-02-29 The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone Dual cut retron editors for genomic insertions and deletions
WO2025063625A1 (ko) * 2023-09-18 2025-03-27 포항공과대학교 산학협력단 Dna 결합 단백질 특이적 결합 부위를 포함하는 조작된 레트론 및 이의 용도
KR20250042094A (ko) 2023-09-18 2025-03-26 포항공과대학교 산학협력단 Dna 결합 단백질 특이적 결합 부위를 포함하는 조작된 레트론 및 이의 용도
WO2025128871A2 (en) 2023-12-13 2025-06-19 Renagade Therapeutics Management Inc. Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5434070A (en) * 1989-02-24 1995-07-18 The University Of Medicine And Dentistry Of New Jersey Reverse transcriptases from Escherichia coli and Myxococcus xanthus
EP1517992B1 (en) * 2002-06-05 2013-08-21 Her Majesty the Queen in Right of Canada, as represented by the Minister of Agriculture and Agri-Food Retrons for gene targeting
US20050026109A1 (en) * 2003-07-30 2005-02-03 Buchanan L. Stephen Multi-tapered dental files
US20170204399A1 (en) * 2014-08-15 2017-07-20 Massachusetts Institute Of Technology Genomically-encoded memory in live cells
KR101922989B1 (ko) * 2016-05-13 2018-11-28 연세대학교 산학협력단 CRISPR/Retron 시스템을 이용한 유전체상의 치환 변이 생성과 추적 방법
ES2985812T3 (es) * 2016-09-09 2024-11-07 The Board Of Trustees Of The Leland Stanfordjunior Univ Edición genómica de precisión de alto rendimiento
WO2018081535A2 (en) * 2016-10-28 2018-05-03 Massachusetts Institute Of Technology Dynamic genome engineering
WO2018191525A1 (en) * 2017-04-12 2018-10-18 President And Fellows Of Harvard College Method of recording multiplexed biological information into a crispr array using a retron

Also Published As

Publication number Publication date
WO2021050822A1 (en) 2021-03-18
IL291128A (en) 2022-05-01
JP2022548062A (ja) 2022-11-16
US20220307007A1 (en) 2022-09-29
KR20220081988A (ko) 2022-06-16
JP2024102277A (ja) 2024-07-30
AU2020346880B2 (en) 2025-04-03
EP4028512A1 (en) 2022-07-20
AU2020346880A1 (en) 2022-04-21
US20230125704A1 (en) 2023-04-27
CA3154384A1 (en) 2021-03-18
CN119859624A (zh) 2025-04-22
US20250188442A1 (en) 2025-06-12
CN114667344A (zh) 2022-06-24
BR112022004453A2 (pt) 2022-06-21
EP4028512A4 (en) 2023-09-20

Similar Documents

Publication Publication Date Title
MX2022003091A (es) Retroelemento bacteriano modificado con produccion de adn mejorada.
EA201991443A1 (ru) ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9
AR123323A1 (es) Edición genómica de reparación dependiente de homología mejorada
PH12017502281A1 (en) Thermostable cas9 nucleases
PH12021551114A1 (en) Crispr-cas12j enzyme and system
MX2024007924A (es) Edicion genomica multiplexada.
MX2021003995A (es) Plasmido que contiene una secuencia que codifica un arnm con una cola de poli(a) segmentada.
EP2571512A4 (en) NEW DNA BINDING PROTEINS AND USES THEREOF
EA201990860A1 (ru) Рнк-направляемые модифицирующие нуклеиновые кислоты ферменты и способы их применения
EA201990861A1 (ru) Рнк-направляемые модифицирующие нуклеиновые кислоты ферменты и способы их применения
MX2019014264A (es) Un metodo de amplificacion de transcriptoma unicelular.
MX391337B (es) Sistemas de replicón de arterivirus recombinantes y usos de estos.
EA201890565A1 (ru) Композиции и способы улучшения специфичности в геномной инженерии с применением рнк-направляемых эндонуклеаз
FI3604532T3 (fi) Uusia crispr-entsyymejä ja järjestelmiä
EA201590794A8 (ru) Рекомбинантные нейротоксины clostridium botulinum
EA201390444A1 (ru) Производство бутанола из монооксида углерода рекомбинантным микроорганизмом
MX2024002327A (es) Sistemas y metodos para direccion con arn guia puntual (arngp) de adn endogeno y fuente.
WO2015160895A3 (en) Modified transposases for improved insertion sequence bias and increased dna input tolerance
MX2016001315A (es) Variantes de enzimas.
EA201070184A1 (ru) Бакуловирусные векторы, включающие повторные кодирующие последовательности с дифференциальными неоднозначностями кодонов
MX2018010288A (es) Sistema de transposon y metodos de uso.
CY1120947T1 (el) Βακτηριακο στελεχος για την εκφραση ανασυνδυασμενης πρωτεϊνης, με ελλειμματικο σε πρωτεαση degp που διατηρει τη δραση σαπερονης, και knocked out tsp kai ptr γονιδια
MX2024000277A (es) Microarns modificados con 5-halouracilo y su uso en el tratamiento del cancer.
MX2020005724A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
NZ601950A (en) Method for producing pyripyropene